Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC Monograph User Fees Totaling $22m To $34m Floated In Senate Discussion Draft

Executive Summary

Bulk of user fees would be raised through facility fees, under Sens. Isakson and Casey’s discussion draft, but there's little time to add the changes to FDA user fee reauthorization bills already moving in Congress.

Advertisement

Related Content

OTC Monograph User Fees Still On The Table, But Not In Legislation
OTC Monograph User Fee Goals Document Beats Authorization To Finish Line
Two-Tier OTC Monograph Approach Could Come With User Fee Revamp
Two-Tier OTC Monograph Approach Could Come With User Fee Revamp
Breakthrough-Style Program For ANDAs Added To House User Fee Bill
All Roads For OTC Policy Improvements Lead To User Fees, FDA Suggests
“No End In Sight” For Completing OTC Monographs – CDER Director Woodcock

Topics

Advertisement
UsernamePublicRestriction

Register

PS120696

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel